Version 1
: Received: 3 August 2018 / Approved: 3 August 2018 / Online: 3 August 2018 (16:05:54 CEST)
How to cite:
Fukushima, H.; Takemura, K.; Suzuki, H.; Koga, F. Impact of Sarcopenia as a Prognostic Biomarker of Bladder Cancer. Preprints2018, 2018080077. https://doi.org/10.20944/preprints201808.0077.v1
Fukushima, H.; Takemura, K.; Suzuki, H.; Koga, F. Impact of Sarcopenia as a Prognostic Biomarker of Bladder Cancer. Preprints 2018, 2018080077. https://doi.org/10.20944/preprints201808.0077.v1
Fukushima, H.; Takemura, K.; Suzuki, H.; Koga, F. Impact of Sarcopenia as a Prognostic Biomarker of Bladder Cancer. Preprints2018, 2018080077. https://doi.org/10.20944/preprints201808.0077.v1
APA Style
Fukushima, H., Takemura, K., Suzuki, H., & Koga, F. (2018). Impact of Sarcopenia as a Prognostic Biomarker of Bladder Cancer. Preprints. https://doi.org/10.20944/preprints201808.0077.v1
Chicago/Turabian Style
Fukushima, H., Hiroaki Suzuki and Fumitaka Koga. 2018 "Impact of Sarcopenia as a Prognostic Biomarker of Bladder Cancer" Preprints. https://doi.org/10.20944/preprints201808.0077.v1
Abstract
Sarcopenia, the degenerative and systemic loss of skeletal muscle mass, indicates patient frailty and impaired physical function. Sarcopenia can be caused by multiple factors, including advanced age, lack of exercise, poor nutritional status, inflammatory diseases, endocrine diseases, and malignancies. Recently, growing evidence has indicated the importance of sarcopenia in the management of patients with various cancers. Sarcopenia is associated with not only higher rates of treatment-related complications but also worse prognosis in cancer-bearing patients. In this article, we conducted a systematic literature review regarding the significance of sarcopenia as a prognostic biomarker of bladder cancer. We also reviewed recent studies focusing on the prognostic role of changes in skeletal muscle mass during the course of treatment in bladder cancer patients.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
